Transient Corticosteroid Treatment Permanently Amplifies the Th2 Response in a Murine Model of Asthma

Ryan E. Wiley*, Monika Cwiartka, David Alvarez, David C. Mackenzie, Jill R. Johnson, Susanna Goncharova, Lennart Lundblad, Manel Jordana

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Corticosteroids (CS) remain the most efficacious pharmacotherapeutic option for the management of asthma. Although the acute anti-inflammatory effects of CS treatment have been amply documented both clinically and experimentally, recent human data intimate that exposure to CS may be associated with retrograde immune phenomena, including enhanced synthesis of IgE in vivo and elevated Th2 cytokine production in vitro. We have investigated the long-term immunologic effects of CS treatment in a murine model of allergic airway inflammation. CS treatment during initial exposure to OVA or upon long-term Ag rechallenge remarkably attenuated eosinophilic airway inflammation and airway hyperresponsiveness. Interestingly, however, Th2 cytokine production by cultured splenocytes from CS-treated mice was significantly elevated, while IFN-γ synthesis was depressed. Moreover, mice rechallenged with OVA several weeks after CS intervention during allergic sensitization not only developed airway inflammation, but also exhibited enhanced Th2 cytokine production in lymphoid tissues and OVA-specific IgE in serum. This amplification of the systemic immune response was associated with an intact APC compartment during CS-conditioned sensitization to OVA. These data indicate that immune processes underlying the allergic phenotype remain impervious to CS treatment and raise the possibility that treatment with CS during sensitization may amplify elements of the allergen-specific immune response.

Original languageEnglish
Pages (from-to)4995-5005
Number of pages11
JournalJournal of Immunology
Issue number8
Publication statusPublished - 15 Apr 2004


Dive into the research topics of 'Transient Corticosteroid Treatment Permanently Amplifies the Th2 Response in a Murine Model of Asthma'. Together they form a unique fingerprint.

Cite this